These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 15758266)
21. Constitutive up-regulation of integrin-mediated adhesion of tumor-infiltrating lymphocytes to osteoblasts and bone marrow-derived stromal cells. Tanaka Y; Mine S; Hanagiri T; Hiraga T; Morimoto I; Figdor CG; van Kooyk Y; Ozawa H; Nakamura T; Yasumoto K; Eto S Cancer Res; 1998 Sep; 58(18):4138-45. PubMed ID: 9751626 [TBL] [Abstract][Full Text] [Related]
22. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice. Kim SJ; Uehara H; Karashima T; Shepherd DL; Killion JJ; Fidler IJ Clin Cancer Res; 2003 Mar; 9(3):1200-10. PubMed ID: 12631626 [TBL] [Abstract][Full Text] [Related]
23. Suppressing NFAT increases VEGF signaling in hemangiomas. Acevedo LM; Cheresh DA Cancer Cell; 2008 Dec; 14(6):429-30. PubMed ID: 19061833 [TBL] [Abstract][Full Text] [Related]
24. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production. Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905 [TBL] [Abstract][Full Text] [Related]
25. Differential expression of VEGF ligands and receptors in prostate cancer. Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639 [TBL] [Abstract][Full Text] [Related]
26. Understanding bone metastases: the key to the effective treatment of prostate cancer. Fidler IJ Clin Adv Hematol Oncol; 2003 May; 1(5):278-9. PubMed ID: 16224421 [No Abstract] [Full Text] [Related]
27. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548 [TBL] [Abstract][Full Text] [Related]
28. [Atypical bone metastasis in a patient with prostatic carcinoma]. Morelli G; Tozzini A; Orsitto E; Calderazzi A; Giannotti P Radiol Med; 1995 May; 89(5):725-7. PubMed ID: 7617923 [No Abstract] [Full Text] [Related]
29. Oxidized low-density lipoprotein and upregulated expression of osteonectin and bone sialoprotein in vascular smooth muscle cells. Farrokhi E; Samani KG; Chaleshtori MH Lab Med; 2014; 45(4):297-301. PubMed ID: 25316660 [TBL] [Abstract][Full Text] [Related]
30. Serum bone sialoprotein levels and bone metastases. Uccello M; Malaguarnera G; Vacante M; Motta M J Cancer Res Ther; 2011; 7(2):115-9. PubMed ID: 21768695 [TBL] [Abstract][Full Text] [Related]
31. Mechanisms of bone metastasis. Roodman GD N Engl J Med; 2004 Apr; 350(16):1655-64. PubMed ID: 15084698 [No Abstract] [Full Text] [Related]
32. Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway. Kim DS; Franklyn JA; Boelaert K; Eggo MC; Watkinson JC; McCabe CJ J Clin Endocrinol Metab; 2006 Nov; 91(11):4603-11. PubMed ID: 16926250 [TBL] [Abstract][Full Text] [Related]
34. An in vivo model of prostate carcinoma growth and invasion in bone. Fisher JL; Schmitt JF; Howard ML; Mackie PS; Choong PF; Risbridger GP Cell Tissue Res; 2002 Mar; 307(3):337-45. PubMed ID: 11904770 [TBL] [Abstract][Full Text] [Related]
35. Prostate cancer cell adhesion to quiescent endothelial cells is not mediated by beta-1 integrin subunit. Cooper CR; McLean L; Mucci NR; Poncza P; Pienta KJ Anticancer Res; 2000; 20(6B):4159-62. PubMed ID: 11205242 [TBL] [Abstract][Full Text] [Related]
36. Nestin regulates prostate cancer cell invasion by influencing the localisation and functions of FAK and integrins. Hyder CL; Lazaro G; Pylvänäinen JW; Roberts MW; Qvarnström SM; Eriksson JE J Cell Sci; 2014 May; 127(Pt 10):2161-73. PubMed ID: 24610946 [TBL] [Abstract][Full Text] [Related]
40. Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo. van der Pluijm G; Sijmons B; Vloedgraven H; van der Bent C; Drijfhout JW; Verheijen J; Quax P; Karperien M; Papapoulos S; Löwik C Am J Pathol; 2001 Sep; 159(3):971-82. PubMed ID: 11549590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]